Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation

Corry, June, Poon, Wendy, McPhee, Narelle, Milner, Alvin D., Cruickshank, Deborah, Porceddu, Sandro V., Rischin, Danny and Peters, Lester J. (2009) Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck, 31 7: 867-876. doi:10.1002/hed.21044


Author Corry, June
Poon, Wendy
McPhee, Narelle
Milner, Alvin D.
Cruickshank, Deborah
Porceddu, Sandro V.
Rischin, Danny
Peters, Lester J.
Title Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation
Journal name Head and Neck-Journal for the Sciences and Specialties of the Head and Neck   Check publisher's open access policy
ISSN 1043-3074
1097-0347
Publication date 2009-07-01
Sub-type Article (original research)
DOI 10.1002/hed.21044
Volume 31
Issue 7
Start page 867
End page 876
Total pages 10
Place of publication Hoboken, NJ, United States
Publisher John Wiley & Sons
Language eng
Formatted abstract
Background: Percutaneous endoscopic gastrostomy (PEG) tubes have largely replaced nasogastric tubes (NGTs) for nutritional support of patients with head and neck cancer undergoing curative (chemo) radiotherapy without any good scientific basis. Methods. A prospective study was conducted to compare PEG tubes and NGTs in terms of nutritional outcomes, complications, patient satisfaction, and cost.

Results: There were 32 PEG and 73 NGT patients. PEG patients sustained significantly less weight loss at 6 weeks post-treatment (median 0.8 kg gain vs 3.7 kg loss, p < .001), but had a high insertion site infection rate (41%), longer median duration of use (146 vs 57 days, p < .001), and more grade 3 dysphagia in disease-free survivors at 6 months (25% vs 8%, p = .07). Patient self-assessed general physical condition and overall quality of life scores were similar in both groups. Overall costs were significantly higher for PEG patients.

Conclusion: PEG tube use should be selective, not routine, in this patient population.
Keyword Percutaneous endoscopic gastrostomy tube
Nasogastric tube
Head and neck cancer
Chemoradiation
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 70 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 89 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 18 Apr 2012, 22:04:18 EST by System User on behalf of Medicine - Princess Alexandra Hospital